Avatrombopag Maleate Patent Expiration

1. Doptelet patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7638536 AKARX INC 2-Acylaminothiazole derivative or salt thereof
Jul, 2027

(3 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8765764 AKARX INC 2-acylaminothiazole derivative or salt thereof
Jan, 2023

(1 year, 5 months ago)

US8338429 AKARX INC 2-acylaminothiazole derivative or salt thereof
Jun, 2023

(1 year, 15 days ago)




Drug Exclusivity Drug Exclusivity Expiration
New Indication(I-802) Jun 26, 2022
New Chemical Entity Exclusivity(NCE) May 21, 2023
Orphan Drug Exclusivity(ODE-246) Jun 26, 2026

NCE-1 date: 21 May, 2022

Market Authorisation Date: 21 May, 2018

Treatment: Treatment of thrombocytopenia in an adult patient with chronic liver disease who is scheduled to undergo a procedure; Treatment of thrombocytopenia in an adult patient with chronic immune thrombocytop...

Dosage: TABLET

More Information on Dosage

DOPTELET family patents

Family Patents